Kangmei Pharmaceutical Co., Ltd. (SHA: 600518)
China flag China · Delayed Price · Currency is CNY
2.340
-0.020 (-0.85%)
Nov 18, 2024, 3:00 PM CST

Kangmei Pharmaceutical Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
255.55102.52-2,6887,918-31,085-4,661
Upgrade
Depreciation & Amortization
340.48340.48365.69603.22644.83695.14
Upgrade
Other Amortization
28.1928.1927.7335.19133.15109.55
Upgrade
Loss (Gain) From Sale of Assets
-19.61-19.61-0.98-64.0144.9619.03
Upgrade
Asset Writedown & Restructuring Costs
99.9799.97307.462,6431,508587.82
Upgrade
Loss (Gain) From Sale of Investments
-44.4-44.4-0.75-188.794.59-767.71
Upgrade
Provision & Write-off of Bad Debts
-238.47-238.47213.411,1921,00334.95
Upgrade
Other Operating Activities
-52.9196.51278.142,57726,0272,972
Upgrade
Change in Accounts Receivable
215.15215.15-339.53-746.883,130956.6
Upgrade
Change in Inventory
-93.01-93.01-253.621,6661,9121,752
Upgrade
Change in Accounts Payable
-896.42-896.421,321-15,587-2,2981,177
Upgrade
Change in Other Net Operating Assets
---0.59-8.93-122.48
Upgrade
Operating Cash Flow
-413.9-317.52-749.96214.211,0312,882
Upgrade
Operating Cash Flow Growth
----79.23%-64.21%843.03%
Upgrade
Capital Expenditures
-88.84-99.74-48.12-171.63-301.73-473.2
Upgrade
Sale of Property, Plant & Equipment
64.9952.251.5577.91,1353.6
Upgrade
Divestitures
17.359.85-57.72-0.7429.25
Upgrade
Investment in Securities
----0.53-313.05
Upgrade
Other Investing Activities
0.15-0.550.04--41.46
Upgrade
Investing Cash Flow
-6.35-37.64-46.02-36.51832.06-168.76
Upgrade
Short-Term Debt Issued
---127.64--
Upgrade
Long-Term Debt Issued
----10,57211,176
Upgrade
Total Debt Issued
---127.6410,57211,176
Upgrade
Short-Term Debt Repaid
----97.03--
Upgrade
Long-Term Debt Repaid
--72.71-94.95-48.66-11,419-12,701
Upgrade
Total Debt Repaid
-72.71-72.71-94.95-145.69-11,419-12,701
Upgrade
Net Debt Issued (Repaid)
-72.71-72.71-94.95-18.05-847.07-1,525
Upgrade
Issuance of Common Stock
---1,800--
Upgrade
Common Dividends Paid
---0.9-13.82-1,032-2,547
Upgrade
Dividends Paid
---0.9-13.82-1,032-2,547
Upgrade
Other Financing Activities
-2.21-48.14-21.010.252.7726.89
Upgrade
Financing Cash Flow
-74.91-120.85-116.861,768-1,876-4,045
Upgrade
Foreign Exchange Rate Adjustments
-0.0100-0.04-0.250.35
Upgrade
Net Cash Flow
-495.17-476.01-912.841,946-13.13-1,331
Upgrade
Free Cash Flow
-502.74-417.27-798.0842.58729.672,409
Upgrade
Free Cash Flow Growth
----94.16%-69.71%-
Upgrade
Free Cash Flow Margin
-9.64%-8.56%-19.09%1.03%13.48%21.05%
Upgrade
Free Cash Flow Per Share
-0.04-0.04-0.060.000.050.49
Upgrade
Cash Interest Paid
0.910.911.06--3.28
Upgrade
Cash Income Tax Paid
291.37211.36284.45235.31295.57304.44
Upgrade
Levered Free Cash Flow
-195.77-278.02117.24-6,02921,9684,071
Upgrade
Unlevered Free Cash Flow
-161.18-242.92166.55-5,39123,3205,476
Upgrade
Change in Net Working Capital
614.53640.19-471.463,953-39,589-6,308
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.